Xiaoyi Wang

1.3k total citations
39 papers, 918 citations indexed

About

Xiaoyi Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoyi Wang has authored 39 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Xiaoyi Wang's work include Fibroblast Growth Factor Research (4 papers), MicroRNA in disease regulation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Xiaoyi Wang is often cited by papers focused on Fibroblast Growth Factor Research (4 papers), MicroRNA in disease regulation (4 papers) and Ubiquitin and proteasome pathways (4 papers). Xiaoyi Wang collaborates with scholars based in China and United States. Xiaoyi Wang's co-authors include Guosheng Ren, Jinxiang Tan, Xinrong Luo, Ran Liang, Ke Zheng, Xinliang Su, Yuan Shi, Dejuan Yang, Peng Li and Tingxiu Xiang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaoyi Wang

37 papers receiving 909 citations

Peers

Xiaoyi Wang
Liwei Lang United States
Katharina Röck Germany
Viktor Todorović United States
Karina G. Zecchin Brazil
Chantal Vercamer France
Yunhee Lee South Korea
Nicholas J. Sullivan United States
Liwei Lang United States
Xiaoyi Wang
Citations per year, relative to Xiaoyi Wang Xiaoyi Wang (= 1×) peers Liwei Lang

Countries citing papers authored by Xiaoyi Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoyi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyi Wang more than expected).

Fields of papers citing papers by Xiaoyi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyi Wang. The network helps show where Xiaoyi Wang may publish in the future.

Co-authorship network of co-authors of Xiaoyi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyi Wang. A scholar is included among the top collaborators of Xiaoyi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyi Wang. Xiaoyi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xinyu, et al.. (2025). Bibliometric analysis of global research trends in delivery systems for breast cancer immunotherapy. Discover Oncology. 16(1). 1829–1829.
2.
Yuan, Wenzheng, et al.. (2025). 5-Fluorouracil induces ferroptosis in breast cancer cells via targeting SLC7A11. Biochemical and Biophysical Research Communications. 770. 151972–151972.
3.
Wang, Xiaoyi, Tianxu Liu, Wei Lv, et al.. (2025). Sleep deprivation-induced sympathetic activation promotes pro-tumoral macrophage phenotype via the ADRB2/KLF4 pathway to facilitate NSCLC metastasis. iScience. 28(5). 112321–112321. 1 indexed citations
4.
Yang, Xianfeng, et al.. (2024). An optimized CRISPRCas9-based gene editing system for efficiently generating homozygous edited plants in rubber tree (Hevea brasiliensis). Industrial Crops and Products. 222. 119740–119740. 4 indexed citations
5.
Wang, Xiaoyi, et al.. (2024). Clinicopathological differences between patients with schistosomal appendicitis and non schistosomal appendicitis: A retrospectively study of past ten years. World Journal of Clinical Cases. 13(2). 96557–96557. 1 indexed citations
6.
Wang, Xiaoyi, et al.. (2023). Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica. Scientific Reports. 13(1). 15115–15115. 1 indexed citations
7.
Zhu, Siyu, Xiaoyi Wang, Hui Xie, & Lizhi Liu. (2023). Comprehensive analysis of circular RNAs in nasopharyngeal cancer. Genes & Genomics. 45(10). 1339–1346. 2 indexed citations
8.
Huang, Jing, Chenchen Liu, Ye Yang, et al.. (2022). The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial. Translational Psychiatry. 12(1). 185–185. 23 indexed citations
9.
Wu, Jiajin, Chenkui Miao, Yuhao Wang, et al.. (2022). SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner. Journal of Translational Medicine. 20(1). 603–603. 9 indexed citations
10.
Chen, Yuru, Jiazheng Sun, Jiazhou Liu, et al.. (2022). Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. Journal of Translational Medicine. 20(1). 615–615. 31 indexed citations
11.
Yi, Ziying, Yunhai Li, Yushen Wu, et al.. (2020). <p>Circular RNA 0001073 Attenuates Malignant Biological Behaviours in Breast Cancer Cell and Is Delivered by Nanoparticles to Inhibit Mice Tumour Growth</p>. OncoTargets and Therapy. Volume 13. 6157–6169. 31 indexed citations
12.
Liao, Chaoliang, Min Li, Namei Li, et al.. (2019). Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(2). 158540–158540. 32 indexed citations
13.
Yuan, Hongyan, Xiaoyi Wang, Chunmei Shi, et al.. (2018). Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis. Scientific Reports. 8(1). 5717–5717. 13 indexed citations
14.
Yi, Ziying, Dejuan Yang, Xuelian Liao, et al.. (2017). PSME3 induces epithelial–mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer. Experimental Cell Research. 358(2). 87–93. 26 indexed citations
15.
Zhang, Xindan, et al.. (2015). Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: A systematic review and meta-analysis. Molecular and Clinical Oncology. 3(3). 663–671. 62 indexed citations
16.
Shi, Yuan, Xinrong Luo, Peng Li, et al.. (2014). miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REGγ. Cancer Letters. 358(1). 27–36. 116 indexed citations
17.
Li, Dan, Qing Qin, Xiaoyi Wang, et al.. (2013). Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model. Oncology Reports. 31(3). 1287–1295. 8 indexed citations
18.
Wang, Xiaoyi, Hongyuan Li, Yuxian Wei, et al.. (2013). Main complications and results of treatment with intra-arterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer. Molecular and Clinical Oncology. 1(4). 745–748. 6 indexed citations
19.
Yin, Xuedong, Xinrong Luo, Hongyuan Li, et al.. (2013). Livin promotes progression of breast cancer through induction of epithelial–mesenchymal transition and activation of AKT signaling. Cellular Signalling. 25(6). 1413–1422. 35 indexed citations
20.
Wang, Xiaoyi, et al.. (2010). REG gamma: a potential marker in breast cancer and effect on cell cycle and proliferation of breast cancer cell. Medical Oncology. 28(1). 31–41. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liwei Lang Breakdown of academic impact, for papers by Katharina Röck Breakdown of academic impact, for papers by Viktor Todorović Breakdown of academic impact, for papers by Karina G. Zecchin Breakdown of academic impact, for papers by Chantal Vercamer Breakdown of academic impact, for papers by Yunhee Lee Breakdown of academic impact, for papers by Nicholas J. Sullivan
Rankless by CCL
2026